Patent · US Active

Compositions and methods for analyzing modified nucleotides

US10619200B2 · kind B2 · utility

3Cited by
4References
38Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 2016
Grant dateApr 14, 2020
Priority date
Expiry dateDec 29, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/154
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A method for identifying the location and phasing of modified cytosines (C) in long stretches of nucleic acids is provided. In some embodiments, the method may comprise (a) reacting a first portion of a nucleic acid sample containing at least one C and/or at least one modified C with a DNA glucosyltransferase and a cytidine deaminase to produce a first product and optionally reacting a second portion of the sample with a dioxygenase and a cytidine deaminase to produce a second product and; (b) comparing the sequences from the first and optionally the second product obtained in (a), or amplification products thereof, with each other and/or an untreated reference sequence to determine which Cs in the initial nucleic acid fragment are modified. A modified TET methylcytosine dioxygenase that is more efficient at converting methylcytosine to carboxymethylcytosine is also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.